Aclaris Therapeutics (ACRS)
(Delayed Data from NSDQ)
$1.22 USD
-0.02 (-1.61%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $1.28 +0.06 (4.92%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.24 |
Last EPS Surprise | 14.29% |
ABR | 2.78 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.77 |
Next Year | -0.68 |
EPS (TTM) | -1.37 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.74M | 1.95M | 8.09M | 8.22M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 2.50M | 2.75M | 10.19M | 13.20M |
Low Estimate | 0.66M | 0.66M | 4.37M | 2.63M |
Year ago Sales | 1.87M | 9.28M | 31.25M | 8.09M |
Year over Year Growth Est. | -6.79% | -78.98% | -74.13% | 1.67% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.18 | -0.77 | -0.68 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.17 | -0.14 | -0.68 | -0.51 |
High Estimate | -0.12 | -0.10 | -0.53 | -0.40 |
Low Estimate | -0.24 | -0.29 | -1.08 | -1.35 |
Year ago EPS | -0.42 | -0.41 | -1.55 | -0.77 |
Year over Year Growth Est. | 54.76% | 56.10% | 50.32% | 12.25% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.18 | -0.77 | -0.68 |
7 Days Ago | -0.19 | -0.18 | -0.77 | -0.68 |
30 Days Ago | -0.19 | -0.18 | -0.78 | -0.69 |
60 Days Ago | -0.20 | -0.19 | -0.81 | -0.73 |
90 Days Ago | -0.20 | -0.19 | -0.81 | -0.73 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.19 | -0.14 | -0.68 | -0.51 |
Zacks Consensus Estimate | -0.19 | -0.18 | -0.77 | -0.68 |
Earnings ESP | 0.00% | 22.22% | 12.18% | 25.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.24 | -0.30 | -0.41 | -0.42 | NA |
Estimate | -0.28 | -0.37 | -0.48 | -0.45 | NA |
Difference | 0.04 | 0.07 | 0.07 | 0.03 | 0.05 |
Surprise | 14.29% | 18.92% | 14.58% | 6.67% | 13.62% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more